Skip to main content
. 2022 Nov 18;17:63. doi: 10.1186/s13722-022-00346-x

Table 3.

Restrictions on inpatient buprenorphine and methadone ordering

Medication Restriction on inpatient ordering* N (%)
Buprenorphine (n = 22) No restriction 10 (45%)
Restriction based on provider specialty** 6 (27%)
Only if receiving treatment prior to admission 3 (14%)
Only physicians with X-waiver*** 3 (14%)
Pain management only 1 (5%)
Methadone (n = 23) No restriction 9 (39%)
Restriction based on provider specialty** 10 (43%)
Only if receiving treatment prior to admission 3 (13%)
Only physicians with X-waiver*** 2 (9%)

*Restriction categories are not mutually exclusive, some pharmacies reported multiple restrictions

**Varying combination of hospitalists, psychiatry, addiction medicine, pain specialists

***X-waivers, Drug Abuse Treatment Act of 2000 waiver